“…Since the review, there have been two additional studies of bolus-tracking perfusion imaging with a paramagnetic agent in schizophrenia (Bellani et al, 2011; Peruzzo et al, 2011). Together, these studies illustrate several findings in schizophrenia: low and inverse hemispheric CBV as indirectly measured through contrast enhancement (CE) (Brambilla et al, 2007); increased CBV in the cerebellum (Loeber et al, 1999), caudate, and occipital cortex (Cohen et al, 1995); no alterations in CBV, CBF, or MTT in the cerebrum or cerebellum (Bellani et al, 2011); decreased frontal cortex CBV and CBF only when using a best predictor model containing clinical state, age, and length of illness (Peruzzo et al, 2011); variable time-to-peak (TTP) in the caudate (Fabene et al, 2007); and increased perfusion in the prefrontal cortex, temporal lobe, and posterior parietal cortices after dopamine receptor D1 agonist administration (Mu et al, 2007). Importantly, none of these studies used a region of interest-based analysis to report hemodynamic properties in the hippocampus in schizophrenia, even though functional abnormalities have been reported in this medial temporal lobe structure.…”